Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Capital Limited reports lower first-half revenue, earnings

(Sharecast News) - Capital Limited reported lower first-half revenue and earnings on Thursday, but said improving momentum across all divisions supports upgraded full-year guidance. For the six months ended 30 June, revenue fell 6% year-on-year to $159.2m, while adjusted EBITDA dropped 25% to $32.1m and adjusted operating profit declined 33% to $17.9m.

Net profit after tax rose 54% to $14.8m, helped by $19.3m of investment gains, but excluding portfolio effects and exceptional items, NPAT fell 82% to $2.1m.

The London-listed firm said EBITDA margins narrowed to 20.2% from 25.3%.

Capex more than halved to $20.4m, and net debt dropped 36% to $55.4m.

An interim dividend of 1.3 cents per share was declared, unchanged from last year.

"Through the first half of 2025, the group has seen improved momentum across all business divisions and looking forward we see a clear pathway that will continue to build on this - both in revenue growth and a recovery in margins, returns and cash flows," said executive chair Jamie Boyton.

"We had also highlighted at the 2024 results that margins would bottom in the first half of 2025, and the performance in the second quarter supports this."

The drilling division increased average rig utilisation to 74% from 69% a year earlier, aided by new exploration contracts, though average monthly revenue per operating rig fell 6.9% to $190,000.

Recent wins included long-term grade control contracts with Allied Gold and Barrick, and a three-year borehole drilling deal with Reko Diq Mining.

Mining operations at Reko Diq have begun ramping up, with full capacity targeted for mid-2026.

MSALABS posted a record quarter in the second quarter, commissioning new laboratories in the US and Saudi Arabia and continuing to expand its network of Chrysos PhotonAssay units.

Contract wins included a feasibility study with Rio Tinto and new work in Namibia and Mauritania.

Capital said it now expected 2025 revenue of $320m to $340m, up from previous guidance of $300m to $320m, with MSALABS revenue seen at $55m to $65m.

The company said it anticipated a stronger second half, supported by new drilling contracts, the Reko Diq ramp-up, and further growth in laboratory volumes.

At 1037 BST, shares in Capital Limited were down 2.08% at 92.24p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.